We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Biomarker Identifies Early Clinical CV Disease

By LabMedica International staff writers
Posted on 19 Jul 2017
Print article
Coronary artery disease (CAD) is one of the leading causes of morbidity and mortality worldwide, and the economic, social, and costs associated with treating CAD are very high. The severity of coronary artery lesions has been proven to be associated with the risk of future cardiovascular events.

The role of homocysteine (Hcy) in the pathogenesis of coronary artery disease (CAD) is controversial, as decreased Hcy levels have not demonstrated consistent clinical benefits. Recent studies propose that S-adenosylhomocysteine (SAH), and not Hcy, plays a role in cardiovascular disease (CVD).

Scientists at the Tianjin Medical University General Hospital (Tianjin, China) recruited 160 hospitalized patients with chest pain, aged between 40 and 80 years between March 2016 and September 2016. Patients with atherosclerosis (AS) and CAD were confirmed by coronary angiography. After the patients had fasted overnight, for a minimum of 12 hours, venous blood samples were collected in ethylenediaminetetraacetic acid (EDTA) anticoagulation tubes before coronary angiography.

Plasma Hcy levels were estimated by enzymatic cycling methods. Plasma SAH and S-adenosylmethionine (SAM) concentrations were measured using high performance liquid chromatography (HPLC). The serum folate and serum vitamin B12 concentrations were measured using Immulite Chemiluminescent kits performed on the IMMULITE 2000 XPi analyzer. Levels of total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, creatinine, and fasting blood glucose were measured using routine methods. Low-density lipoprotein (LDL) cholesterol levels were measured using the colorimetric method.

The investigators found that SAH levels were significantly higher in the CAD group (23.09 ± 2.4 nmol/L) than in the AS group (19.2 ± 1.5 nmol/L). While the AS group had higher values for SAM/SAH (5.1 ± 0.7 versus 4.1 ± 1.1), levels of SAM, Hcy, folate, and vitamin B12 were similar in the two groups. Coronary artery lesions were associated with SAH. Plasma SAH concentrations are independently associated with coronary artery lesions among patients undergoing coronary angiography. Plasma SAH might be a novel biomarker for the early clinical identification of CVD.

The authors concluded that that the levels of plasma SAH were independently correlated with coronary lesions among patients undergoing coronary angiography. This positive association suggests that SAH may be a novel and better biomarker for the risk of coronary lesions when compared to Hcy. The study was published on July 4, 2017, in the journal Clinica Chimica Acta.

Related Links:
Tianjin Medical University General Hospital

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
H.pylori Test
Humasis H.pylori Card

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.